Table 5.
Parameters or aspects | CRISPR-based assays | RT-PCR assays |
---|---|---|
Target gene | E and N | ORF1ab, N, E, and RdRP |
TAT | 30–40 min | 4 h |
Assay results | Qualitative | Quantitative |
Specific instrument required | No | Yes |
FDA or EUA approval | Not yet | Yes |
E envelope protein, N nucleocapsid protein, EUA European emergency use authorization, FDA US Food and Drug Administration, ORF open reading frame, RdRp RNA-dependent RNA polymerase, TAT turn-around time.